-
FAAH Related Products (93)
Related Products (93)
-
VDM11
0 ImagesVDM11 is a potent and selective anandamide membrane transporter (AMT) inhibitor. VDM11 inhibits FAAH and MAGL and may act as an alternative FAAH substrate.
-
Carprofen (Standard)
0 ImagesCarprofen (Standard) is the analytical standard of Carprofen. This product is intended for research and analytical applications. Carprofen is a nonsteroid anti-inflammatory agent, acts as a multi-target FAAH/COX inhibitor, with IC50s of 3.9 μM, 22.3 μM and 78.6 μM for COX-2, COX-1 and FAAH, respectively.
-
PF-622
0 ImagesCat. No.: HY-10867CAS No.: 898235-65-9PF-622 is a selective FAAH inhibitor, and can be used for study of analgesic and anxiolytic/antidepressant.
-
FAAH/MAGL-IN-3
0 ImagesCat. No.: HY-146342CAS No.: 2848719-34-4
-
3-Decyl-5,5'-diphenyl-2-thioxo-4-imidazolidinone
0 ImagesCat. No.: HY-116710CAS No.: 875014-22-53-Decyl-5,5'-diphenyl-2-thioxo-4-imidazolidinone (compound 45) is a potential inhibitor of fatty acid amide hydrolase (FAAH) (pI50: 5.89) and is active against CB(1) and CB(2) ) Lack of affinity for cannabinoid receptors.
-
Carprofen-13C,d3
0 ImagesCat. No.: HY-B1227S1CAS No.: 2012598-34-2
-
Dual FAAH/sEH-IN-1
0 ImagesCat. No.: HY-144738CAS No.: 2756099-59-7Dual FAAH/sEH-IN-1 (compound 3) is a high affinity dual sEH (soluble epoxide hydrolase) and FAAH (fatty acid amide hydrolase) inhibitor, with IC50 values of 9.6 and 7 nM, respectively. Dual FAAH/sEH-IN-1 shows antinociception against the inflammatory phase.
-
FAAH/cPLA2α-IN-1
0 ImagesCat. No.: HY-149654CAS No.: 1696401-38-3FAAH/cPLA2α-IN-1 is a dual inhibitor of FAAH and cPLA2α with IC50s of 32 and 47 nM, respectively.
-
Acetylhydrolase-IN-1
0 ImagesCat. No.: HY-102054CAS No.: 79637-91-5Acetylhydrolase-IN-1 is a 1-Alkyl-2-acetylglycerophosphocholine esterase (Alkylacetyl-GPC: acetylhydrolase) inhibtor.
-
MM-433593
0 ImagesCat. No.: HY-115004CAS No.: 1006604-91-6MM-433593 is a potent and selective inhibitor of fatty acid amide hydrolase-1 (FAAH-1) that is orally administered to inhibit pain, inflammation, and related disorders. Pharmacokinetic studies of MM-433593 in macaques revealed a biphasic elimination profile with a rapid distribution phase and a slower elimination phase, with a systemic clearance of 8-11 mL/min/kg. MM-433593 exhibits moderate oral bioavailability (14-21%) and its metabolism primarily involves oxidation of the methyl group on the indole ring, resulting in a variety of sulfate, glucuronide, or glutathione-conjugated metabolites.
-
SA57
0 ImagesCat. No.: HY-103463CAS No.: 1346169-63-8SA57 is a potent, selective FAAH inhibitor with IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH. SA57 also inhibits the 2-arachidonoylglycerol hydrolases MAGL (IC50s of 410 nM and 1.4 μM for mouse and human MAGL) and mouse α/β-hydrolase domain-containing protein 6 (mABHD6; IC50 of 850 nM), but not other brain serine hydrolases.
-
FAAH/MAGL-IN-2
0 ImagesCat. No.: HY-143264CAS No.: 2765077-82-3
-
FAAH-IN-7
0 ImagesCat. No.: HY-151919CAS No.: 3037600-36-2FAAH-IN-7 is a reversible and potent FAAH inhibitor with an IC50 value of 8.29 nM. FAAH-IN-7 suppresses oxidative stress in 1321N1 astrocytes and exhibits notable neuroprotective effect in ex vivo neuroinflammation model.
-
URB532
0 ImagesCat. No.: HY-120369CAS No.: 195140-79-5URB532 is an inhibitor for fatty acid amide hydrolase (FAAH) with an IC50 of 396 nM. URB532 increases levels of arachidonic acid acetamide (AEA), palmitoylethanolamide (PEA), and oleamide (OEA) in the rat brain, and exhibits anxiolytic and analgesic effects.
-
Macamide B (Standard)
0 ImagesCat. No.: HY-N2365RCAS No.: 74058-71-2Synonyms: N-Benzylpalmitamide (Standard); N-Benzylhexadecanamide (Standard); Macamide 1 (Standard)Macamide B (Standard) is the analytical standard of Macamide B. This product is intended for research and analytical applications. Macamide B (N-Benzylhexadecanamide; Macamide 1) is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH).
